Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.
about
Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapyThe pivotal role of pathology in the management of lung cancerNon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipPrognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer.A pessimistic explanatory style is prognostic for poor lung cancer survivalEpidemiology of lung cancer prognosis: quantity and quality of life.Time-varying pattern of postoperative recurrence risk of early-stage (T1a-T2bN0M0) non-small cell lung cancer (NSCLC): results of a single-center study of 994 Chinese patients.Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patientsPreliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [18F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT.Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.How close are we to customizing chemotherapy in early non-small cell lung cancer?Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts.Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancerHeterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients.Relationship between deficits in overall quality of life and non-small-cell lung cancer survivalFER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancerMetformin use and young age lung cancer: A case series reportUpregulation of RNA Processing Factors in Poorly Differentiated Lung Cancer Cells.Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation.Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease.Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinomaProteomics in detection and monitoring of asthma and smoking-related lung diseases.Lung Cancer Staging and Prognosis.Gender-specific survival after surgical resection for early stage non-small cell lung cancer.Regional Emphysema Score Predicting Overall Survival, Quality of Life, and Pulmonary Function Recovery in Early-Stage Lung Cancer Patients.Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer.Porting a cancer treatment prediction to a mobile device.Reevaluation of survival and prognostic factors in pathologic stage I lung adenocarcinoma by the new 2009 TNM classification.The role of Thyroid Transcription Factor-1 and Tumor differentiation in Resected Lung Adenocarcinoma.The relationship between EGFR gain and VHL loss in lung adenocarcinoma and poor patient survival.Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis.Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.T category of non-small cell lung cancer invading the fissure to the adjacent lobe.Perioperative Management May Improve Long-term Survival in Patients After Lung Cancer Surgery: A Retrospective Cohort Study.Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer.
P2860
Q24629542-943B8A69-046C-4E77-8F85-4665C483CD3EQ27010437-B0C57E34-5749-4FB4-A33B-DBDB2C541DD2Q28278682-A433AD57-348A-4E40-BD76-EACC17920B20Q30498101-AF2A5389-42BC-4A0F-A448-7A880752B67CQ30499609-C08DD668-3E7D-4FC0-9471-F74C08865A81Q33786990-EDCDC6F0-D0A1-4197-B2D2-CBA687651990Q34135295-590CC03C-B0CD-47B8-BEB4-9EBA023AFEE1Q34155998-14113336-94A1-41A0-A639-F56006729B86Q34160556-F13DD7BB-AA8F-468E-89DD-23E80861D308Q34538956-2AD921F1-4066-4848-B0A7-7FCA3EBF9370Q35100937-A1194796-0FA0-4590-8078-1DF71A4A19F4Q35146944-932D4665-AE09-46B5-985D-B5DCFE9517FFQ35541769-561ECBFD-E0E1-43DA-967B-9CA805E930B7Q35633965-55D2D71F-6555-4FE9-9B8C-A1523CB50781Q36051720-C1C92A3E-D259-4092-A635-2E41ACE37017Q36058286-C6EA252B-F563-48DC-BB7A-81636BDD4A2BQ36711982-144B1A92-843D-4425-B895-1C30D9124166Q36741232-8FED243E-BC0A-4300-BC3F-BEC958236791Q36804488-E2C37089-8AFC-43D9-986F-799796293297Q37469085-C250D32B-7859-4EC7-A4FC-617D8C8FCCF0Q37536837-BE02E924-E13C-4A72-8BF0-66A87DCD543CQ37540113-142A5D14-AD69-404F-8371-473EE41ED1FBQ37763933-8CD79880-1C1F-4FBD-970E-750E062B50B5Q38830349-B8C7CA60-1DFD-4705-81FC-14FA69D68537Q39185876-98B2CBDB-0C56-4F23-B34C-D764E8600FFFQ40362871-5D582D1B-6205-4E82-A83D-F42ABA926E66Q40629175-BF4403DF-AAEF-4BE2-9578-5B94A5E91AF5Q42260320-525440F3-E2B5-42B8-B544-6C183FEEB5E6Q42948959-18CC1FBA-9EA8-4393-9F0D-ADEC4B06E507Q43884883-8F01CD9C-519F-4894-A91A-82DD5F6ADEAFQ44265153-3F24465E-395D-4B92-89E9-7B5F2F5CAFB1Q44587904-8D65E8EB-CE3F-4DF1-8C4A-C15267D9102CQ44901755-C0C9D1F9-E651-4F01-90C3-64E2A1C940E1Q45276482-431CA172-F6A2-4022-80BA-333A6C8AFD77Q47850449-18A76368-F09E-4698-A9E8-39D63C064651Q48961059-FB297676-2605-4DE8-B02A-6B27E554199FQ50084806-08278B1A-2EC3-43E9-A356-B949B65B3AF4Q52667020-04C2759A-6E64-4D5A-BA43-F8890B63189AQ52732458-304B6139-D854-44F7-9144-F6EA94E5BB0CQ53075503-2AF1D920-4B3D-4EA5-9C40-574A2BF7F091
P2860
Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Histologic grade is an indepen ...... nd 712 population-based cases.
@en
Histologic grade is an indepen ...... nd 712 population-based cases.
@nl
type
label
Histologic grade is an indepen ...... nd 712 population-based cases.
@en
Histologic grade is an indepen ...... nd 712 population-based cases.
@nl
prefLabel
Histologic grade is an indepen ...... nd 712 population-based cases.
@en
Histologic grade is an indepen ...... nd 712 population-based cases.
@nl
P2093
P1476
Histologic grade is an indepen ...... and 712 population-based cases
@en
P2093
Brent A Williams
Claude Deschamps
Hiroshi Sugimura
Marie-Christine Aubry
Randolph S Marks
Scott H Okuno
V Shane Pankratz
P304
P356
10.1016/J.JTCVS.2005.12.057
P407
P50
P577
2006-05-01T00:00:00Z